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a  b  s  t  r  a  c  t
Natamycin  is  an effective,  broad  spectrum  antifungal  with  no reported  resistance,  in contrast  to most
antimicrobials.  It also  exhibits  reduced  (oral  and  topical)  toxicity  to humans,  which  is probably  associated
with  the  lack  of effects  on mammalian  cell  membranes.  In this  paper  we  employ  Langmuir  monolayers
to  mimic  a cell  membrane,  whose  properties  are  interrogated  with various  techniques.  We  found  that
natamycin  has  negligible  effects  on Langmuir  monolayers  of  dipalmitoyl  phosphatidylcholine  (DPPC),  but
it  strongly  affects  cholesterol  monolayers.  Natamycin  causes  the  surface  pressure  isotherm  of  a choles-
terol  monolayer  to  expand  even  at high  surface  pressures  since  it penetrates  into  the  hydrophobic  chains.
It  also reduces  the compressibility  modulus,  probably  because  natamycin  disturbs  the  organization  of
the  cholesterol  molecules,  as  inferred  with  polarization-modulated  infrared  reﬂection  absorption  spec-
troscopy  (PM-IRRAS).  In  mixed  cholesterol/DPPC  monolayers,  strong  effects  from  natamycin  were  only
observed  when  the  cholesterol  concentration  was  50 mol%  or higher,  well  above  its concentration  in a
mammalian  cell  membrane.  For a sterol  concentration  that  mimics  a real cell membrane  in mammals,
i.e.  with  25  mol%  of cholesterol,  the effects  were  negligible,  which  may  explain  why  natamycin  has  low
toxicity  when  ingested  and/or  employed  to treat  superﬁcial  fungal  infections.
© 2014  Elsevier  B.V.  All  rights  reserved.
1. Introduction
Diseases caused by opportunistic fungal infections have become
a major health problem owing to the increasing number of indi-
viduals whose immune system has been compromised by HIV
infection or by administration of immunosuppressive drugs during
cancer treatment and organ transplants [1,2]. This has motivated
the development of new antifungal drugs, including polyene antibi-
otics [3], that are natural drugs typically produced by Streptomyces
spp. [4]. Examples of these polyenes are amphotericin B, nystatin
and natamycin, which are effective antifungals with no reported
resistance since their discovery 50 years ago, in contrast to most
antimicrobials. The mechanism of action appears to be connected
with their high afﬁnity for sterols [5], but controversies exist about
the precise molecular-level mechanism [6], especially with regard
∗ Corresponding author. Tel.: +55 18 3229 5355; fax: +55 18 3221 5682.
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to interaction with cell membranes. The activity of amphotericin
B and nystatin was  normally attributed to malfunction and/or dis-
ruption (leakage) of the lipid bilayer promoted by their binding
to the biomembrane sterols [7], inducing pores or channels and
disturbing the selective permeability of the membrane [1,2,8–11].
Recent ﬁndings have cast doubt on this hypothesis since a modi-
ﬁed amphotericin exhibited antifungal activity without being able
to form pores or channels [6]. As for natamycin, this formation
of pores or channels is not applicable [6,12], and therefore other
mechanisms must prevail [11,13,14].
In this study we  try to explain the low toxicity of natamycin
to mammalian cells, in spite of its afﬁnity to cholesterol, by
investigating the interaction with cell membrane models. We  use
Langmuir monolayers to mimic  a cell membrane for two  main
reasons, namely the ability to probe molecular-level interactions
with vibrational spectroscopy and the possibility of controlling the
model membrane composition. Understanding the interaction with
membranes is crucial because natamycin is a macrolide polyene
antifungal with broad spectrum activity, which is only possible if
the action involves the membrane. Natamycin was ﬁrst isolated
http://dx.doi.org/10.1016/j.colsurfb.2014.06.058
0927-7765/© 2014 Elsevier B.V. All rights reserved.
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in 1955 from a soil sample in Natal province, South Africa, pro-
duced by the bacteria strain named Streptomyces natalensis.  It is
poorly soluble in water, almost insoluble in nonpolar solvents.
Natamycin powder is stable in the dark, with no loss of activity,
but it is degraded in aqueous suspensions if exposed to UV-light,
oxidants and heavy metals [15,16]. When applied to food surfaces,
natamycin does not affect the food quality (color, texture and ﬂa-
vor), being safe for consumption because its oral absorption is
negligible [16–18]. Due to its low toxicity, natamycin is approved as
a natural food additive, can be used topically for treating mycoses
[19,20], and is the only topical antifungal approved by the US Food
and Drug Administration (FDA) for topical ophthalmic use [20–22].
Macrolide polyene antibiotics have been successfully studied
with the Langmuir monolayer technique [10,23–30]. Here we  used
binary mixtures of phosphatidylcholine (PC) and cholesterol (Chol),
which are the most abundant phospholipid and sterol in mam-
malian membranes [28,31–33], as model membrane, in addition
to neat monolayers of dipalmitoyl phosphatidylcholine (DPPC) and
cholesterol for comparison.
2. Materials and methods
2.1. Adsorption kinetics and surface pressure isotherms
Polyene antifungal natamycin was supplied by Fluka, choles-
terol was purchased from Sigma-Aldrich and synthetic phospho-
lipid dipalmitoylphosphatidylcholine (DPPC) was obtained from
Avanti Polar Lipids. Fig. 1 displays the chemical structure of
the three compounds. DPPC was chosen for this study because
phosphatidylcholine (PC) is the most abundant component in
membranes of mammals, being an important constituent of the
alveolar ﬂuid [34]. All reagents were used without further puriﬁ-
cation. Spreading stock solutions (0.5 mg/mL) for the lipids were
made daily by dissolving each compound separately in chloroform,
with mixtures being produced in the desired proportions. Aqueous
solution/suspension of natamycin is quite stable [15], which is why
aqueous formulations are used in therapeutic applications [20–22]
and as food additives [16–18]. In ultrapure water (pH = 5.5–6)
natamycin molecules are slightly positively charged, since their
isoelectric point is at pH = 6.5 [15,35]. Although natamycin solu-
bility in water has been estimated to be 0.03–1.0 g/L [15,35], our
preliminary investigations led to irreproducible results (data not
shown) when 0.04 g/L was  used for the stock solution. This could
be associated with aggregation, since a broadening was observed
in the UV–vis. bands for natamycin at 0.04 g/L in Fig. S1 in the Sup-
porting information. Therefore, all experiments were performed
with 0.02 g/L (black line) for the natamycin stock solution. The sub-
phase employed was  made with ultrapure water (pH = 5.5–6) at
21 ± 0.5 ◦C.
The kinetics of adsorption for natamycin at the air/water inter-
face, which could contain a lipid monolayer, was  investigated using
a cylindrical Teﬂon container with a diameter of 4 cm and a vol-
ume  of 10 mL  adapted on a KSV mini trough. Surface pressure
was measured with the Wilhelmy method [10]. Aliquots from lipid
stock solutions were spread on the water surface, with a volume
chosen to reach the desired ﬁnal pressure. Natamycin was either
injected into the subphase or dissolved in the subphase from the
start. Surface pressure isotherms for the lipid monolayers were
carried out in a mini KSV Langmuir Teﬂon trough with 250 mL
volume. The number of natamycin molecules dissolved in the sub-
phase (0.15 mol) was about 3 times the number of lipid molecules
spread (0.054 mol) at the air–water interface. This total amount of
natamycin (0.4 g/mL) in the subphase is well below the safe limit
established by USA FDA (20 ppm) [35] and it is also about ten times
below the minimum inhibitory concentration (MIC) [19–21,47,48].
Since signiﬁcant oxidation of cholesterol molecules at the inter-
face may  occur after 40 min  [32,36,37], the isotherm experiments
were performed within 40 min  of monolayer spreading. A waiting
time of 20 min  elapsed for chloroform evaporation and monolayer
stabilization. The scan rate for the symmetric barrier compression
was 30 cm2/min. At least three isotherms were acquired for each
composition to ensure reproducibility, and the curves shown are
representative.
2.2. Analysis of isotherms
The mechanical properties of the monolayers were analyzed by
calculating the compression modulus Cs−1 from the ﬁrst derivative
(1) [10,23–28,31,38,39]
C−1s = −A
(
∂
∂A
)
T
(1)
Fig. 1. Chemical structures of the antifungal natamycin, the sterol cholesterol and the phospholipid dipalmitoylphosphatidylcholine (DPPC).
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where A is the area per molecule at pressure . According to
Davis and Rideal [40] the monolayer phases can be identiﬁed
by the compression modulus values: liquid-expanded phase for
Cs−1 = 12.5–50 mN/m,  liquid phase for Cs−1 = 50–100 mN/m,  liquid-
condensed for Cs−1 = 100–250 mN/m and condensed (solid) for
Cs−1 > 250 mN/m. The higher Cs−1 the less elastic the monolayer
is. The collapse pressure is deﬁned at Cs−1 = 0.
The thermodynamic properties (stability and miscibility) of the
mixed monolayers were studied by calculating the excess free
energy of mixing (Gexc) at a given surface pressure () deﬁned
in the following equation [10,23,26–28,31,38,41,42]
Gexc = N
∫ 
0
(A12 − A1X1 + A2X2)d (2)
where N is the Avogrado’s number; A12 is the measured area per
molecule for a mixed monolayer; A1 and A2 are the molecular areas
for each pure component, with X1 and X2 being their respective
mole fractions. Non-zero values for Gexc indicate molecular-level
interactions, which may  be attractive or repulsive depending on
whether Gexc is negative or positive. Hence, the positive sign of
the Gexc value indicates segregation of the components, while the
most negative Gexc characterizes the most thermodynamically
stable monolayer, of which the great miscibility of components is
secured [10,26,28,42].
2.3. Brewster angle microscopy (BAM)
The monolayer morphology was monitored using a Brewster
angle microscope (BAM), model BAM 2 Plus (Nano Film Technology,
Germany). The microscope (light source and camera) was  coupled
to a NIMA Langmuir trough, and the compression speed used during
the imaging procedure was the same as for recording the surface
pressure isotherms. In this experimental set-up [23,24,31,43,44],
the p-polarized light beam incident at the Brewster angle (about
53◦) on a clean water surface is not reﬂected. On the other hand,
differences in the refraction index owing to monolayer formation
leads to reﬂected light, thus forming an Image [23,24,31,43,44]. In
the gray scale, the darkest regions represent the clean water surface
(no light reﬂection), while the brightest correspond to monolayer
domains [23,24,31,43,44].
2.4. PM-IRRAS analysis
The spectra for polarization-modulated infrared reﬂection-
absorption spectroscopy (PM-IRRAS) were obtained using a KSV
PMI 550 instrument (KSV, Finland) coupled to a mini KSV Lang-
muir trough. The polarized infrared beam was positioned to reach
the monolayer at an incident angle of 80◦, relative to the nor-
mal  water surface. The total acquisition time for each spectrum
was 5 min  and the compression speed was the same in the surface
pressure isotherms. This experimental set-up is optimized to study
Langmuir ﬁlms at the air–water interface [38,39,44–46], since the
signal-to-noise ratio is magniﬁed and the interference from water
vapor and carbon dioxide is minimized with the modulation of the
polarization. Under the conditions used, positive bands in the spec-
tra indicate transition moments preferentially on the surface plane,
whereas negative bands indicate preferential orientation perpen-
dicular to the surface.
3. Results and discussion
3.1. Effect of natamycin on DPPC and cholesterol monolayers
Our adsorption kinetics results (Fig. S2A–C) are attached in the
Supporting Information. Natamycin has no surface activity for the
concentrations used in this work, which is inferred from the lack
of changes in surface tension (Fig. S2A) for aqueous solutions. This
is consistent with the results obtained by Demel et al. [30] who
showed that, compared with other polyenes (amphotericin B, nys-
tatin and ﬁlipin), only natamycin spread at the air–water interface
exhibited a poor quality isotherm, with little increase in surface
pressure (∼5 mN/m), even when compression was carried out until
reaching a very low area per molecule (∼8 A˚2) [29]. Natamycin has
apparently no afﬁnity toward DPPC, as no adsorption was observed
according to the surface pressure measurements in Fig. S2B, in
the Supporting information. In contrast, the surface pressure of a
cholesterol monolayer changed with time, owing to adsorption of
natamycin, as indicated in Fig. S2C especially for already-prepared
subphases containing natamycin.
The lack of afﬁnity toward DPPC and the strong effect on
cholesterol, inferred from the adsorption kinetics results above,
are conﬁrmed with the surface pressure isotherms in Fig. 2. While
natamycin had no effect on a DPPC monolayer, a large shift occurred
for the cholesterol monolayer, and this is indicated quantitatively
in the extrapolated areas in Table 1. The lack of interaction with
DPPC is consistent with several pieces of evidence in the literature,
for natamycin in aqueous solutions did not affect phosphocholine
(PC) spherules [47] and DPPC unilamellar vesicles [11,12].
As for the effect on cholesterol monolayers, in addition to
expanding the surface pressure isotherm, natamycin causes the
compressibility modulus to decrease considerably, as shown in the
inset of Fig. 2. Therefore, natamycin penetrates into the cholesterol
Fig. 2. Surface pressure () vs. mean molecular area compression isotherms for
DPPC and cholesterol spread at air/water interface. The subphase used was  ultrapure
water, pH 5.8, T = 21 ◦C, with or without addition of natamycin. The inset shows the
in-plane elasticity (Cs−1) values versus surface pressure for the monolayers, with
Cs−1 being calculated from the isotherms using Eq. (1) .
Table 1
Values for area per molecule, collapse pressure and in-plane elasticity (Cs−1) for
DPPC, cholesterol monolayers and their binary mixture with and without natamycin
in  the subphase.
Monolayer Area per molecule (±2 A˚2) Cs−1 ( = 30 mN/m)
DPPC 52 138
+Natamycin 53 140
XCHOL = 0.25 46 172
+Natamycin 47 163
XCHOL = 0.5 43 358
+Natamycin 47 192
XCHOL = 0.75 41 474
+Natamycin 44 469
Cholesterol 38 650
+Natamycin 49 463
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Fig. 3. Brewster angle microscopy (BAM) images for cholesterol monolayers in the absence or in the presence of natamycin at various surface pressures (mN/m) and areas
per  lipid (Å2).
monolayer and turns it less rigid. In subsidiary experiments we
observed that natamycin expands the monolayer of the negatively
charged dipalmitoyl phosphatidylglycerol (DPPG), but to a much
lesser extent than it does for cholesterol (Fig. S3 in the Supporting
information).
Fig. S4 in the Supporting information shows two  sets of images
(A–C) and (D–F) corresponding, respectively, to BAM images for
DPPC monolayer spread at the surface of a clean water subphase
and of a subphase containing natamycin. The latter did not alter
the morphology of a DPPC monolayer made up of characteris-
tic domains owing to coexistence of the liquid-expanded (dark
regions) and liquid-condensed (bright regions) phases [32,34] (Fig.
S4A, B, D and E), then evolving to a continuous, bright ﬁlm when the
liquid-condensed phase dominates (Fig. S4C and F). The domains
in cholesterol monolayers are not as well deﬁned as in DPPC, but
one may  nevertheless note that the overall morphology is signif-
icantly affected by natamycin. For an area per lipid of 70 A˚2 in
Fig. 3A, the surface pressure is zero for a cholesterol monolayer
and, as expected, the morphology is characteristic of the gas phase
containing circular domains, while the addition of natamycin in
Fig. 3D causes a predominance of clusters of irregularly-shaped
domains. The morphology of cholesterol monolayers at ﬁxed areas
per molecule are also affected by the expansion effect caused by
natamycin. For instance, at 60 A˚2 the cholesterol monolayer con-
taining natamycin appeared almost fully continuous (Fig. 3E), while
pure cholesterol ﬁlms are still segregated (Fig. 3B).
In contrast, according to Fig. 4, natamycin promoted changes
in the PM-IRRAS spectra of a cholesterol monolayer; though the
shifts were almost within the resolution of the instrument, clear
trends were observed. At 5 mN/m in Fig. 4A, there is an increase for
both asymmetric (2937 cm−1 shifted to 2944 cm−1) and symmetric
stretch of CH2 groups (2851 cm−1 shifted to 2856 cm−1), and for
the symmetric stretch of CH3 (2886 cm−1 shifted to 2890 cm−1);
at 10 mN/m in Fig. 4B, the vibration frequencies increased for both
symmetric stretch of CH2 (2851 cm−1 shifted to 2853 cm−1) and
CH3 (2886 cm−1 shifted to 2890 cm−1), while the relative inten-
sity between the asymmetric stretch bands of CH2 (2934 cm−1) and
CH3(2953 cm−1) decreased. Because intensity variations are corre-
lated to changes in molecular orientation [38,48], one may infer
that natamycin disturbs the organization of cholesterol molecules,
probably by increasing the distance between them. Surprisingly,
at 30 mN/m (Fig. 4C), which corresponds to the pressure in a real
membrane [49,50], no signiﬁcant change is noted for any of the
Fig. 4. PM-IRRAS spectra obtained for cholesterol monolayer at (A) 5 mN/m,  (B)
10  mN/m and (C) 30 mN/m.
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Fig. 5. Surface pressure () vs. mean molecular area (A) isotherms for DPPC and cholesterol and their mixtures (cholesterol mol fraction, XChol) spread at the air/water
interface. The subphase used was ultrapure water, pH 5.8, T = 21 ◦C, with or without the addition of natamycin. The inset shows the in-plane elasticity (Cs−1) versus surface
pressure obtained from the data in Fig. 6 using Eq. (1).
bands. This lack of change may  perhaps be related to the large
rigidity (i.e. compression modulus) for cholesterol in a condensed
state, which makes it difﬁcult to observe dynamic changes in the
vibrational spectra.
3.2. Effect of natamycin on DPPC–cholesterol mixed monolayers
Cholesterol is known to induce condensation in DPPC mono-
layers [31,32,38], which was indeed observed in the surface
pressure ()–area per molecule (A) isotherms in Fig. 5. The incor-
poration of natamycin in the subphase caused reduction in the
condensing effect, i.e. a shift to larger areas per lipid, especially
at medium-high concentrations of cholesterol.
This behavior is quantiﬁed in Table 1 with the extrapolated areas
to zero pressure, in addition to the in-plane elasticity (Cs−1) taken
from the inset in Fig. 5. As expected, the effect from natamycin
on a monolayer that mimics the sterol composition of a mam-
malian membrane [33] (XChol = 0.25) is very small and the pressure
dependence for Cs−1 is practically the same as for the monolayer
without natamycin. One could expect the largest effects to take
place for XChol = 0.75, which does not occur probably because the
amount of cholesterol that may  penetrate into a DPPC monolayer
is limited. For PC bilayers, for instance, above 37.5 mol% domains
of cholesterol plaques are formed [51]. The changes induced by
natamycin on the DPPC monolayer with XChol = 0.5 were signiﬁcant,
especially in the in-plane elasticity. These results are consis-
tent with atomic force microscopy (AFM) data taken with mixed
DPPC/cholesterol Langmuir–Blodgett (LB) ﬁlms [52]. The ﬁlms con-
taining 10–30 mol% of cholesterol were smooth, densely packed,
while for 50 mol% of cholesterol the ﬁlm was  rough owing to the
decreased solubility of cholesterol in the DPPC monolayer.
From a thermodynamic viewpoint, another way to assess the
condensing effect from cholesterol is to calculate the excess free
energy of mixing (Gexc), which is negative as shown in Fig. 6A
for various cholesterol concentrations. These negative Gexc values
gradually increase with the surface pressure and indicate stronger
van der Waals interactions (higher packing and miscibility) [10,26]
between DPPC and cholesterol molecules. Moreover, the minimum
Fig. 6. Excess free energy of mixing (Gexc) versus ﬁlm composition (cholesterol mol fraction, XChol) at different surface pressures for DPPC/cholesterol mixtures spread on
the  surface of (A) ultrapure water and (B) aqueous solution of natamycin. Error bars represent the standard deviation for measurements taken in triplicate (n = 3).
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Gexc occurs at XChol = 0.25 and, therefore corresponds to the mix-
ture of the highest thermodynamic stability [28], the cholesterol
content of which is below the 37.5 mol% limit for solubility already
mentioned [51]. The effect from natamycin is shown in Fig. 6B,
where the condensing effect is diminished (Gexc decreased) for
all mixtures, but is reverted (positive Gexc values) only at higher
cholesterol contents (XChol = 0.50, 0.75 and 1.0). For these high
concentrations, the expansion caused by natamycin overtakes the
condensing effect from cholesterol on DPPC.
4. Conclusions
Natamycin does not form a Gibbs monolayer, adopting a pref-
erential location in the bulk as suggested by Weissmann and Sessa
[47]. Natamycin does not affect DPPC monolayers but causes large
expansion in cholesterol monolayers. For DPPC-cholesterol mix-
tures, natamycin only has considerable effects when the cholesterol
concentration is large (50 mol% or higher). For the mixture mim-
icking a real cell membrane in mammals, i.e. with ca. 25 mol% of
cholesterol [33], its great thermodynamic stability (higher pack-
ing) seems to protect it from natamycin effects. This explains why
natamycin administration (oral and topical) is safe for mammals
[16,22,35]. Additionally, the interaction of natamycin with DPPG
was found to be weaker than with cholesterol. One may  conclude,
therefore, that only membranes rich in sterols, cholesterol in our
case, are amenable to signiﬁcant action from natamycin.
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